The convalescent sera option for containing COVID-19.J Clin Invest. 2020 04 01; 130(4):1545-1548.JCI
Links
MeSH
Pub Type(s)
Historical Article
Journal Article
Research Support, N.I.H., Extramural
Language
eng
PubMed ID
32167489
Clinical Trial Links
Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia
Citation
Casadevall, Arturo, and Liise-Anne Pirofski. "The Convalescent Sera Option for Containing COVID-19." The Journal of Clinical Investigation, vol. 130, no. 4, 2020, pp. 1545-1548.
Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130(4):1545-1548.
Casadevall, A., & Pirofski, L. A. (2020). The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, 130(4), 1545-1548. https://doi.org/10.1172/JCI138003
Casadevall A, Pirofski LA. The Convalescent Sera Option for Containing COVID-19. J Clin Invest. 2020 04 1;130(4):1545-1548. PubMed PMID: 32167489.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The convalescent sera option for containing COVID-19.
AU - Casadevall,Arturo,
AU - Pirofski,Liise-Anne,
PY - 2021/04/01/pmc-release
PY - 2020/3/14/pubmed
PY - 2020/4/9/medline
PY - 2020/3/14/entrez
KW - COVID-19
SP - 1545
EP - 1548
JF - The Journal of clinical investigation
JO - J Clin Invest
VL - 130
IS - 4
SN - 1558-8238
UR - https://www.unboundmedicine.com/medline/citation/32167489/full_citation
L2 - https://doi.org/10.1172/JCI138003
DB - PRIME
DP - Unbound Medicine
ER -